Recap: Amicus Therapeutics Q1 Earnings

Amicus Therapeutics FOLD reported its Q1 earnings results on Monday, May 9, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Amicus Therapeutics missed estimated earnings by 20.0%, reporting an EPS of $-0.3 versus an estimate of $-0.25.

Revenue was up $12.31 million from the same period last year.

Last quarter the company missed on EPS by $0.13 which was followed by a 2.71% drop in the share price the next day.

Here's a look at Amicus Therapeutics's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.16	-0.18	-0.22	-0.24
EPS Actual	-0.29	-0.19	-0.19	-0.25
Revenue Estimate	83.28M	80.11M	73.36M	71.65M
Revenue Actual	82.15M	79.55M	77.41M	66.40M

To track all earnings releases for Amicus Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar